Disease Management and Assessment Archives - Page 16 of 22

Virtual Forum Summary: Engaged Practice: Methods For Managing The Complexity Of Bipolar Disorder & Related Conditions

Article July 14, 2017

This summary was developed utilizing the full recorded presentation of this virtual forum, which is available on PsychU for all members free of charge. For full sourcing and polling results,… Read More

The Sequenced Treatment Alternatives To Relieve Depression: The STAR*D Study & Its Implications

Video July 12, 2017

In this presentation, Stephen Murray, PharmD, MBA discusses the STAR*D study, its findings, limitations, and what practical clinical questions it addressed. For more on this topic, check out: The STAR*D Trials… Read More

Cerebral White Matter Structure Is Associated With DSM-5 Schizophrenia Symptom Dimensions

Article July 11, 2017

Key Messages This diffusion tensor imaging (DTI) study examined associations between white matter (WM) microstructure and the severity of the 5 main Diagnostic and Statistical Manual of Mental Disorders, Fifth… Read More

Neuroinflammation & White Matter Pathology In Schizophrenia: Systematic Review

Article July 11, 2017

Key Messages White matter (WM) pathology and neuroinflammation have each been associated with schizophrenia in separate lines of research. This systematic literature review examined whether a relationship exists between WM… Read More

Cognitive Impairment In Manic Bipolar Patients: Important, Understated, Significant Aspects

Article June 28, 2017

Key Messages Compared with healthy individuals, patients with bipolar I disorder (BD I) experience cognitive deficits, including impairment of sustained attention, memory, and executive function. These deficits have been observed… Read More

Neuroinflammation & Psychiatric Illness

Article June 26, 2017

Key Messages Multiple lines of evidence support the role of neuroinflammatory processes in the pathogenesis of psychiatric illnesses. Neuropsychiatric disorders are frequently found among patients with autoimmune conditions; in addition,… Read More

Genetics Of Schizophrenia & Smoking: An Approach To Studying Their Comorbidity Based On Epidemiological Findings

Article June 26, 2017

Key Messages An association between tobacco smoking and schizophrenia has been consistently described in the literature. This meta-analysis showed a 5-fold increased rate of current smoking in patients with schizophrenia… Read More

Pathophysiology & Evolving Theories In Schizophrenia

Video June 7, 2017

This presentation is part 2 in a series focusing on the psychopharmacology of schizophrenia. This presentation reviews regions of the brain and neurotransmitters implicated in schizophrenia, as well as the… Read More

Looking Beyond Mood & Psychosis: A Focus On Neurocognition

On-Demand Webinar June 7, 2017

Historically, cognitive impairment was considered an artifact of patients’ symptoms, attention, or motivation problems, and as such, was an underappreciated feature of schizophrenia. However, recent research has shown cognitive impairment… Read More

Depressive Residual Symptoms Are Associated With Lower Adherence To Medication In Bipolar Patients Without Substance Use Disorder: Results From The FACE-BD Cohort

Article June 6, 2017

Key Messages Poor treatment adherence is common among patients with bipolar disorder (BD). There is a lack of robust data on factors that negatively influence adherence behavior. This multicenter study… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: